Prognostic factors of survival in patients treated with nab-paclitaxel plus gemcitabine regimen for advanced or metastatic pancreatic cancer: a single institutional experience
about
Prognostic relevance of lactate dehydrogenase in advanced pancreatic ductal adenocarcinoma patients.nab-Paclitaxel for the treatment of pancreatic cancer.Musashi2 promotes the development and progression of pancreatic cancer by down-regulating Numb protein.Individualized radiotherapy (iRT) concepts for locally advanced pancreatic cancer (LAPC): indications and prognostic factors.Survivin silencing and TRAIL expression using oncolytic adenovirus increase anti-tumorigenic activity in gemcitabine-resistant pancreatic cancer cells.
P2860
Prognostic factors of survival in patients treated with nab-paclitaxel plus gemcitabine regimen for advanced or metastatic pancreatic cancer: a single institutional experience
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Prognostic factors of survival ...... ingle institutional experience
@ast
Prognostic factors of survival ...... ingle institutional experience
@en
type
label
Prognostic factors of survival ...... ingle institutional experience
@ast
Prognostic factors of survival ...... ingle institutional experience
@en
prefLabel
Prognostic factors of survival ...... ingle institutional experience
@ast
Prognostic factors of survival ...... ingle institutional experience
@en
P2860
P50
P356
P1433
P1476
Prognostic factors of survival ...... ingle institutional experience
@en
P2093
Giovanni Lo Re
Luisa Foltran
P2860
P304
P356
10.18632/ONCOTARGET.3143
P407
P577
2015-04-01T00:00:00Z